Consistently, a limited dilution assay (LDA) showed that the frequency of tumor-initiating cells increased by 4-fold in the NOD1-overexpressing group (Fig. 4P), whereas NOD1-knockdown had the opposite effects (Figs. 4Q–T, S12F and S12G). This evidence concerns the gene NOD1 and neoplasm.